Company / Debt per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD Debt per Share History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$28.38
FY2017
5-year range
-
FY2016-FY2017
Trend
-100.0%
vs FY2016
Sector context
#9 of 82
Health Care
What the data says
TEVA PHARMACEUTICAL INDUSTRIES LTD's debt per share of $28.38 is higher than 89% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
28.38 in FY2017. Top quartile in the Health Care sector.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 82This company $28.38 Sector average $126.59
▼
-77.6% below sector average
Key checks
Key Insights
- In FY2017, debt per share decreased 100.0% year-over-year.
- Ranks #9 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $28.38 | -100.0% |
| FY2016 | $33843912.59 | - |
As of FY2017 · SEC 10-K · Updated Mar 28, 2026